US Patent Issued to REGENXBIO on July 22 for "Scalable clarification process for recombinant AAV production" (Maryland Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,365,865, issued on July 22, was assigned to REGENXBIO INC. (Rockville, Md.).

"Scalable clarification process for recombinant AAV production" was invented by Claire G. Zhang (Rockville, Md.), Shaojie Weng (Rockville, Md.), Ya-Chen Chang (Rockville, Md.) and Franz M. Gerner (Rockville, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are scalable methods for the clarification of a composition comprising recombinant Adeno-Associated Virus (rAAV) particles and an impurity."

The patent was filed on April 27, 2019, under Application No. 17/050,608.

*For further information, including images, charts and tables, please visit: http://patft.us...